A decade in the making, trial used a combination of the vaccine with a drug to treat melanoma. The data has been shared with the FDA, and the stock has gone up a lot. It is believed the vaccine could reach market next year. It is personalized and can work with an individualized approach.
Decades of research are finally yielding fruit. This news covers this groundbreaking results from the latest trial.